Get the Stockscreener App
2.155
3.32%
0.045
Entera Bio Ltd stock is traded at $2.155, with a volume of 27,950.
It is up +3.32% in the last 24 hours and down -28.29% over the past month.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
See More
Previous Close:
$2.11
Open:
$2.15
24h Volume:
27,950
Relative Volume:
0.18
Market Cap:
$94.92M
Revenue:
$134.00K
Net Income/Loss:
$-9.93M
P/E Ratio:
-6.3382
EPS:
-0.34
Net Cash Flow:
$-6.72M
1W Performance:
-8.40%
1M Performance:
-28.29%
6M Performance:
+8.46%
1Y Performance:
+21.79%
1-Day Range:
$2.05
$2.22
1-Week Range:
$2.05
$2.474
52-Week Range:
$1.5006
$3.22
Entera Bio Ltd Stock (ENTX) Company Profile
Name
Entera Bio Ltd
Sector
Industry
Phone
972-2-532-7151
Address
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Compare ENTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
2.07 | 96.76M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.07 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
732.59 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.05 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
913.29 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.75 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-22-21 | Initiated | Aegis Capital | Buy |
Entera Bio Ltd Stock (ENTX) Latest News
Why Entera Bio Ltd. (5DT) stock appeals to dividend investorsQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser
Will Entera Bio Ltd. (5DT) stock sustain uptrend momentumStop Loss & Long-Term Safe Investment Ideas - Newser
Will Entera Bio Ltd. (5DT) stock benefit from infrastructure billMarket Activity Summary & Capital Protection Trade Alerts - Newser
Is Entera Bio Ltd. (5DT) stock good for wealth creationEarnings Trend Report & Reliable Entry Point Trade Alerts - Newser
Can Entera Bio Ltd. (5DT) stock sustain revenue momentumWeekly Market Report & Risk Controlled Daily Trade Plans - Newser
Will Entera Bio Ltd. (5DT) stock issue positive guidanceJuly 2025 Market Mood & AI Driven Stock Price Forecasts - Newser
Will Entera Bio Ltd. (5DT) stock enhance shareholder valueJuly 2025 Spike Watch & Low Risk High Win Rate Picks - Newser
How Entera Bio Ltd. (5DT) stock expands through international marketsRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Will Entera Bio Ltd. (5DT) stock hit analyst forecasts2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
Can Entera Bio Ltd. (5DT) stock expand revenue streams2025 Short Interest & High Return Trade Guides - Newser
How Entera Bio Ltd. stock performs in stagflation2025 Volatility Report & Growth Focused Entry Point Reports - Newser
Can Entera Bio Ltd. (5DT) stock surprise markets with earningsTrend Reversal & Reliable Volume Spike Alerts - Newser
Holdings of Entera Bio Ltd (ENTX) are aligned with the stars - Setenews
Can Entera Bio Ltd. stock sustain market leadershipWeekly Trade Summary & Weekly Chart Analysis and Guides - BỘ NỘI VỤ
What drives Entera Bio Ltd stock priceVolume Weighted Average Price & Small Budget Investment Tips - earlytimes.in
Is Entera Bio Ltd 5DT a good long term investmentRisk Adjusted Returns & Low Entry Risk Stocks - earlytimes.in
How Entera Bio Ltd. (5DT) stock compares with market leadersInsider Buying & Weekly Stock Performance Updates - newser.com
Is Entera Bio Ltd. stock a buy in volatile markets2025 Geopolitical Influence & Verified Momentum Stock Alerts - newser.com
Can Entera Bio Ltd. (5DT) stock withstand sector downturnsJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Why Entera Bio Ltd. (5DT) stock is listed among top recommendationsJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Why Entera Bio Ltd. stock remains resilientJuly 2025 Volume & Growth Focused Stock Reports - newser.com
Chart based analysis of Entera Bio Ltd. trends2025 Trading Recap & Reliable Breakout Stock Forecasts - newser.com
Entera Bio Reports Q3 2025 Financial Results - TipRanks
What sentiment indicators say about Entera Bio Ltd. stockJuly 2025 Volume & Smart Investment Allocation Insights - newser.com
Why Entera Bio Ltd. (5DT) stock stays undervaluedJuly 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - newser.com
Will Entera Bio Ltd. (5DT) stock boost dividends furtherJuly 2025 Sector Moves & Growth Focused Stock Reports - newser.com
How Entera Bio Ltd. stock reacts to inflationary pressuresPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Entera Bio Ltd Stock (ENTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):